Literature DB >> 9602344

Epithelial component of lymphoid stroma-rich Warthin's tumour expresses interleukin (IL)-7.

T Takeuchi, H Yamanouchi, Q Yue, Y Ohtsuki.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9602344     DOI: 10.1046/j.1365-2559.1998.0401h.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


× No keyword cloud information.
  5 in total

1.  Overexpression of IL-7 enhances cisplatin resistance in glioma.

Authors:  Lei Cui; Jun Fu; Jesse Chung-Sean Pang; Zhi-Kun Qiu; Xiao-Mei Liu; Fu-Rong Chen; Hong-Liu Shi; Ho-Keung Ng; Zhong-Ping Chen
Journal:  Cancer Biol Ther       Date:  2012-05-01       Impact factor: 4.742

2.  The effect of alendronate on proteome of hepatocellular carcinoma cell lines.

Authors:  Amber Ilyas; Zehra Hashim; Nadia Naeem; Kanwal Haneef; Shamshad Zarina
Journal:  Int J Proteomics       Date:  2014-02-06

3.  [The expressions of IL-7 and IL-7R and the relationship between them with lymph node metastasis and prognosis in non-small cell lung cancer].

Authors:  Jian MING; Qingfu ZHANG; Yanduo JIANG; Xueshan QIU; Xiaozhong BAI
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2010-12

4.  Visualization and identification of IL-7 producing cells in reporter mice.

Authors:  Renata I Mazzucchelli; Søren Warming; Scott M Lawrence; Masaru Ishii; Mehrnoosh Abshari; A Valance Washington; Lionel Feigenbaum; Andrew C Warner; Davis J Sims; Wen Qing Li; Julie A Hixon; Daniel H D Gray; Benjamin E Rich; Matthew Morrow; Miriam R Anver; James Cherry; Dieter Naf; Lawrence R Sternberg; Daniel W McVicar; Andrew G Farr; Ronald N Germain; Keith Rogers; Nancy A Jenkins; Neal G Copeland; Scott K Durum
Journal:  PLoS One       Date:  2009-11-10       Impact factor: 3.240

5.  Potential implications of interleukin-7 in chronic wound healing.

Authors:  Annie Bartlett; Andrew J Sanders; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Exp Ther Med       Date:  2016-04-18       Impact factor: 2.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.